“…These observations are in complete agreement with a substantial number of reports, which have established that nAChR upregulation is a time and dose dependent phenomenon, varying quantitatively and qualitatively according to nAChR subunit composition (Marks et al, 1985;Marks et al, 1986;Pauly et al, 1989;Sanderson et al, 1993), and cell-specific neuronal distribution (Nashmi et al, 2007). Thus, α4β2* nAChRs, which have high affinity for nicotine, are more readily upregulated compared with low-affinity α7 nAChRs, a differential regulation that occurs in mice (Sparks and Pauly, 1999), rats (Mugnaini et al, 2002) and humans (Teaktong et al, 2004). For α7 nAChRs, in particular, we observed a 30% overall increase in [ 125 I]α-bungarotoxin binding sites in nicotine treated WT mice, which is consistent with the magnitude of nicotine-induced upregulation previously reported for the α7 receptor subtype by in vitro (Barrantes et al, 1995;Peng et al, 1997;Ridley et al, 2001) and in vivo studies (Pauly et al, 1991;Rasmussen and Perry, 2006).…”